On July 8, 2025, financial services firm Benchmark, represented by analyst Mark Palmer, announced the initiation of coverage on Semler Scientific (SMLR, Financial) with a 'Buy' rating. This marks a new analytical interest in the company, which is listed on the NASDAQ exchange.
Benchmark introduced a price target for Semler Scientific (SMLR, Financial) at USD 101.00. This is the first time a price target has been set by the analyst, thus no prior target exists for comparison. The initiation of this coverage reflects positively on the company's potential in the market.
Semler Scientific (SMLR, Financial) is positioned as a noteworthy stock, receiving attention from Benchmark as it embarks on providing evaluations and insights into the company's future performance. Investors may want to consider this new coverage as an indicator of potential growth in Semler Scientific's market presence.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Semler Scientific Inc (SMLR, Financial) is $71.00 with a high estimate of $71.00 and a low estimate of $71.00. The average target implies an upside of 82.28% from the current price of $38.95. More detailed estimate data can be found on the Semler Scientific Inc (SMLR) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Semler Scientific Inc's (SMLR, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
